Atlas Trials

Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

Clinical trial NCT04598919 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04598919
Sponsor
National Jewish Health
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis (IPF)
Start date
2020-11-12
Primary completion
2024-09-15
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.